Clinical Trials Insight: 700043064
Phase of Trial: Phase I
Latest Information Update: 05 Mar 2009
At a glance
- Drugs Seliciclib (Primary)
- Indications Nasopharyngeal cancer
- Focus Adverse reactions
- 05 Mar 2009 Results were published in the February 2009 issue of the journal Clinical Cancer Research.
- 05 Mar 2009 New trial record.